eCite Digital Repository
The zinc transporter Zip7 is downregulated in skeletal muscle of insulin-resistant cells and in mice fed a high-fat diet
Citation
Norouzi, S and Adulcikas, J and Henstridge, DC and Sonda, S and Sohal, SS and Myers, S, The zinc transporter Zip7 is downregulated in skeletal muscle of insulin-resistant cells and in mice fed a high-fat diet, Cells, 8, (7) pp. 663. ISSN 2073-4409 (2019) [Refereed Article]
![]() | PDF 1Mb |
Copyright Statement
Copyright 2019 The Authors. Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/
Abstract
Background: The zinc transporter Zip7 modulates zinc flux and controls cell signaling molecules associated with glucose metabolism in skeletal muscle. The present study evaluated the role of Zip7 in cell signaling pathways involved in insulin-resistant skeletal muscle and mice fed a high-fat diet.
Methods: Insulin-resistant skeletal muscle cells were prepared by treatment with an inhibitor of the insulin receptor, HNMPA-(AM)3 or palmitate, and Zip7 was analyzed along with pAkt, pTyrosine and Glut4. Similarly, mice fed normal chow (NC) or a high-fat diet (HFD) were also analyzed for protein expression of Glut4 and Zip7. An overexpression system for Zip7 was utilized to determine the action of this zinc transporter on several genes implicated in insulin signaling and glucose control.
Results: We identified that Zip7 is upregulated by glucose in normal skeletal muscle cells and downregulated in insulin-resistant skeletal muscle. We also observed (as expected) a decrease in pAkt and Glut4 in the insulin-resistant skeletal muscle cells. The overexpression of Zip7 in skeletal muscle cells led to the modulation of key genes involved in the insulin signaling axis and glucose metabolism including Akt3, Dok2, Fos, Hras, Kras, Nos2, Pck2, and Pparg. In an in vivo mouse model, we identified a reduction in Glut4 and Zip7 in the skeletal muscle of mice fed a HFD compared to NC controls.
Conclusions: These data suggest that Zip7 plays a role in skeletal muscle insulin signaling and is downregulated in an insulin-resistant, and HFD state. Understanding the molecular mechanisms of Zip7 action will provide novel opportunities to target this transporter therapeutically for the treatment of insulin resistance and type 2 diabetes.
Item Details
Item Type: | Refereed Article |
---|---|
Keywords: | zinc, zinc transporter, Zip7, insulin signaling pathway, high-fat diet, skeletal muscle, type 2 diabetes, cell signaling |
Research Division: | Biological Sciences |
Research Group: | Biochemistry and cell biology |
Research Field: | Cell metabolism |
Objective Division: | Health |
Objective Group: | Clinical health |
Objective Field: | Clinical health not elsewhere classified |
UTAS Author: | Norouzi, S (Mrs Shaghayegh Norouzi) |
UTAS Author: | Adulcikas, J (Mr John Adulcikas) |
UTAS Author: | Henstridge, DC (Dr Darren Henstridge) |
UTAS Author: | Sonda, S (Dr Sabrina Sonda) |
UTAS Author: | Sohal, SS (Dr Sukhwinder Sohal) |
UTAS Author: | Myers, S (Dr Stephen Myers) |
ID Code: | 133557 |
Year Published: | 2019 |
Web of Science® Times Cited: | 7 |
Deposited By: | Health Sciences |
Deposited On: | 2019-07-02 |
Last Modified: | 2022-08-29 |
Downloads: | 25 View Download Statistics |
Repository Staff Only: item control page